, Volume 34, Issue 4, pp 421–422 | Cite as

Authors’ Reply to Palozzo and Messori: ‘‘Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review’’

  • Bonny Parkinson
  • Adam G. Elshaug
Letter to the Editor


Health Outcome Decision Maker Clinical Indication Economic Cooperation Grey Literature 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Compliances with ethical standards

Conflict of interest

Bonny Parkinson has no conflicts of interest. Adam Elshaug receives salary support as the HCF Research Foundation Principal Research Fellow; holds research Grants from the Commonwealth Fund and Australia’s National Health and Medical Research Council (IDs 1109626 and 1104136); and receives consulting/sitting fees from Cancer Australia, the Capital Markets Cooperative Research Centre–Health Quality Program, NPS MedicineWise (the facilitator of Choosing Wisely Australia), the Royal Australasian College of Physicians (the facilitator of the EVOLVE Programme) and the Australian Commission on Safety and Quality in Health Care.


  1. 1.
    Palozzo AC, Messori A. Comment on: “Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review”. PharmacoEconomics. 2016. doi: 10.1007/s40273-015-0376-6.PubMedGoogle Scholar
  2. 2.
    Parkinson B, Sermet C, Clement F, Crausaz S, Godman B, Garner S, Choudhury M, Pearson SA, Viney R, Lopert R, Elshaug AG. Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review. PharmacoEconomics. 2015;33(9):905–24.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Centre for the Health EconomyMacquarie UniversitySydneyAustralia
  2. 2.Menzies Centre for Health PolicySchool of Public Health, Sydney Medical School, University of SydneySydneyAustralia

Personalised recommendations